MOLINA HEALTHCARE INC (MOH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MOH - US60855R1005 - Common Stock
191.4 USD
-2.34 (-1.21%)
190 USD
-1.4 (-0.73%)
Overall MOH gets a fundamental rating of 5 out of 10. We evaluated MOH against 102 industry peers in the Health Care Providers & Services industry. MOH has only an average score on both its financial health and profitability. MOH is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- MOH had positive earnings in the past year.
- In the past year MOH has reported a negative cash flow from operations.
- Each year in the past 5 years MOH has been profitable.
- Each year in the past 5 years MOH had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 5.62%, MOH belongs to the best of the industry, outperforming 80.39% of the companies in the same industry.
- MOH's Return On Equity of 21.07% is amongst the best of the industry. MOH outperforms 88.24% of its industry peers.
- MOH has a Return On Invested Capital of 11.98%. This is amongst the best in the industry. MOH outperforms 86.27% of its industry peers.
- MOH had an Average Return On Invested Capital over the past 3 years of 17.96%. This is significantly above the industry average of 9.19%.
- The 3 year average ROIC (17.96%) for MOH is well above the current ROIC(11.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROIC | 11.98% |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
1.3 Margins
- MOH has a Profit Margin of 1.98%. This is in the better half of the industry: MOH outperforms 61.76% of its industry peers.
- MOH's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 2.97%, MOH is in line with its industry, outperforming 54.90% of the companies in the same industry.
- In the last couple of years the Operating Margin of MOH has declined.
- MOH has a Gross Margin of 13.91%. This is in the lower half of the industry: MOH underperforms 65.69% of its industry peers.
- MOH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% |
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MOH is creating value.
- Compared to 1 year ago, MOH has less shares outstanding
- The number of shares outstanding for MOH has been reduced compared to 5 years ago.
- The debt/assets ratio for MOH is higher compared to a year ago.
2.2 Solvency
- MOH has an Altman-Z score of 4.35. This indicates that MOH is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 4.35, MOH is doing good in the industry, outperforming 78.43% of the companies in the same industry.
- MOH has a Debt/Equity ratio of 0.92. This is a neutral value indicating MOH is somewhat dependend on debt financing.
- MOH has a Debt to Equity ratio (0.92) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.35 |
ROIC/WACC1.4
WACC8.53%
2.3 Liquidity
- A Current Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
- MOH's Current ratio of 1.68 is fine compared to the rest of the industry. MOH outperforms 65.69% of its industry peers.
- MOH has a Quick Ratio of 1.68. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
- MOH has a better Quick ratio (1.68) than 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
- The earnings per share for MOH have decreased strongly by -16.06% in the last year.
- Measured over the past years, MOH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.16% on average per year.
- MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.65%.
- Measured over the past years, MOH shows a quite strong growth in Revenue. The Revenue has been growing by 19.29% on average per year.
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
3.2 Future
- MOH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.04% yearly.
- The Revenue is expected to grow by 6.09% on average over the next years.
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y5.04%
Revenue Next Year10.59%
Revenue Next 2Y7.26%
Revenue Next 3Y7.1%
Revenue Next 5Y6.09%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 10.37, the valuation of MOH can be described as very reasonable.
- Based on the Price/Earnings ratio, MOH is valued cheaply inside the industry as 90.20% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of MOH to the average of the S&P500 Index (27.47), we can say MOH is valued rather cheaply.
- A Price/Forward Earnings ratio of 13.98 indicates a correct valuation of MOH.
- Based on the Price/Forward Earnings ratio, MOH is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
- When comparing the Price/Forward Earnings ratio of MOH to the average of the S&P500 Index (24.26), we can say MOH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.37 | ||
| Fwd PE | 13.98 |
4.2 Price Multiples
- 100.00% of the companies in the same industry are more expensive than MOH, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.67 |
4.3 Compensation for Growth
- MOH has a very decent profitability rating, which may justify a higher PE ratio.
- MOH's earnings are expected to decrease with -10.35% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.73
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
5. Dividend
5.1 Amount
- MOH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
191.4
-2.34 (-1.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)02-05 2026-02-05/amc
Inst Owners113.06%
Inst Owner Change0.37%
Ins Owners1.33%
Ins Owner Change1.17%
Market Cap9.84B
Revenue(TTM)44.55B
Net Income(TTM)883.00M
Analysts56.3
Price Target175.59 (-8.26%)
Short Float %7.14%
Short Ratio1.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.8%
Min EPS beat(2)-53.34%
Max EPS beat(2)-6.27%
EPS beat(4)1
Avg EPS beat(4)-17.79%
Min EPS beat(4)-53.34%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-7.75%
EPS beat(12)8
Avg EPS beat(12)-3.04%
EPS beat(16)12
Avg EPS beat(16)-1.32%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)2.53%
Min Revenue beat(4)0.69%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)3.12%
Revenue beat(12)10
Avg Revenue beat(12)2.26%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)0.69%
PT rev (3m)-14.42%
EPS NQ rev (1m)-33.12%
EPS NQ rev (3m)-89.62%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)-23.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.37 | ||
| Fwd PE | 13.98 | ||
| P/S | 0.22 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.35 | ||
| P/tB | 4.95 | ||
| EV/EBITDA | 0.67 |
EPS(TTM)18.45
EY9.64%
EPS(NY)13.69
Fwd EY7.15%
FCF(TTM)-11.17
FCFYN/A
OCF(TTM)-8.97
OCFYN/A
SpS866.73
BVpS81.54
TBVpS38.7
PEG (NY)N/A
PEG (5Y)0.73
Graham Number183.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROCE | 16.11% | ||
| ROIC | 11.98% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% | ||
| FCFM | N/A |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.15%
ROCE(5y)23.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
F-Score4
Asset Turnover2.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 56.78% | ||
| Cap/Sales | 0.25% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 4.35 |
F-Score4
WACC8.53%
ROIC/WACC1.4
Cap/Depr(3y)51.53%
Cap/Depr(5y)59.49%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.29%
Profit Quality(3y)92.3%
Profit Quality(5y)171.56%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y5.04%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
Revenue Next Year10.59%
Revenue Next 2Y7.26%
Revenue Next 3Y7.1%
Revenue Next 5Y6.09%
EBIT growth 1Y-19.56%
EBIT growth 3Y15.28%
EBIT growth 5Y10.22%
EBIT Next Year-31.25%
EBIT Next 3Y-9.54%
EBIT Next 5Y3.97%
FCF growth 1Y-128.12%
FCF growth 3Y-35.66%
FCF growth 5Y7.61%
OCF growth 1Y-121.54%
OCF growth 3Y-32.77%
OCF growth 5Y8.21%
MOLINA HEALTHCARE INC / MOH FAQ
Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?
ChartMill assigns a fundamental rating of 5 / 10 to MOH.
What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?
ChartMill assigns a valuation rating of 5 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.
How profitable is MOLINA HEALTHCARE INC (MOH) stock?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for MOH stock?
The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 10.37 and the Price/Book (PB) ratio is 2.35.